Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jacobi

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Critical Care Medicine|February 19, 1998
Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of AmericaN P O'Grady, P S Barie, J Bartlett, et al.
Vaccine: X|December 30, 2024
Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicityCatharina E van Ewijk, Sara Suárez Hernández, Ronald H J Jacobi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of AmericaN P O'Grady, P S Barie, J G Bartlett, et al.
Vaccine|January 11, 2012
Impaired production of TNF-α by dendritic cells of older adults leads to a lower CD8+ T cell response against influenzaWai Ming Liu, Thamar E R Nahar, Ronald H J Jacobi, et al.
Frontiers in Immunology|May 24, 2021
Latent CMV Infection Is Associated With Lower Influenza Virus-Specific Memory T-Cell Frequencies, but Not With an Impaired T-Cell Response to Acute Influenza Virus InfectionSara P H van den Berg, Josien Lanfermeijer, Ronald H J Jacobi, et al.
Frontiers in Immunology|February 15, 2019
Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular ImmunitySietske K Rosendahl Huber, Marion Hendriks, Ronald H J Jacobi, et al.
Cancer Research|November 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease ProgressionJustine J Jacobi, Kristine M Wadosky, Neha Jaiswal, et al.
Iscience|November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiationKanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Cell Reports|December 15, 2021
Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancerMark D Long, Justine J Jacobi, Prashant K Singh, et al.
Frontiers in Immunology|December 3, 2024
Early immune profiling reveals distinct inflammatory responses between children and adults few days after primary SARS-CoV-2 infectionMartijn D B Van de Garde, Alberto Miranda-Bedate, Nening M Nanlohy, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Critical Care Medicine|February 19, 1998
Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of AmericaN P O'Grady, P S Barie, J Bartlett, et al.
Vaccine: X|December 30, 2024
Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicityCatharina E van Ewijk, Sara Suárez Hernández, Ronald H J Jacobi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of AmericaN P O'Grady, P S Barie, J G Bartlett, et al.
Vaccine|January 11, 2012
Impaired production of TNF-α by dendritic cells of older adults leads to a lower CD8+ T cell response against influenzaWai Ming Liu, Thamar E R Nahar, Ronald H J Jacobi, et al.
Frontiers in Immunology|May 24, 2021
Latent CMV Infection Is Associated With Lower Influenza Virus-Specific Memory T-Cell Frequencies, but Not With an Impaired T-Cell Response to Acute Influenza Virus InfectionSara P H van den Berg, Josien Lanfermeijer, Ronald H J Jacobi, et al.
Frontiers in Immunology|February 15, 2019
Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular ImmunitySietske K Rosendahl Huber, Marion Hendriks, Ronald H J Jacobi, et al.
Cancer Research|November 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease ProgressionJustine J Jacobi, Kristine M Wadosky, Neha Jaiswal, et al.
Iscience|November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiationKanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Cell Reports|December 15, 2021
Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancerMark D Long, Justine J Jacobi, Prashant K Singh, et al.
Frontiers in Immunology|December 3, 2024
Early immune profiling reveals distinct inflammatory responses between children and adults few days after primary SARS-CoV-2 infectionMartijn D B Van de Garde, Alberto Miranda-Bedate, Nening M Nanlohy, et al.
Pageof 10